Episurf Medical AB (publ)

EPIS-B · Nasdaq Stockholm · Healthcare

0.07SEK −2.3%last day

Price as of 2 October 2026

The price over the past year, with dividends: +97.8%

Performance

1 month

−4.4%

1 year

+97.8%

3 years, per year

−58.2%

5 years, per year

−54.2%

Largest fall, 3 years

−98.9%

Below the peak now

−99.8%

Volatility, 1 year

129.1%

Return with dividends reinvested.

Key figures

P/E

negative earnings

P/B

0.6

Dividend yield

0.0%

Return on equity

−43.1%

Net margin

–

Market value

35 m USD

Quality, value and trend

Where Episurf Medical stands against every Nordic stock today. 100 is best.

Quality52

Profitability and a sound balance sheet over time. Better than 52% of Nordic stocks.

Value26

The price measured against earnings, assets and cash flow. Better than 26% of Nordic stocks.

Trend91

The price development over the past year. Better than 91% of Nordic stocks.

Combined58

Quality, value and trend together. Better than 58% of Nordic stocks.

About Episurf Medical

Episurf Medical AB (publ) is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 22 employees.

Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally. It provides Episealer Knee for repairing focal cartilage and bone defects to reduce pain and increase mobility in the patient's knee joint; Episealer implant, which is designed to fit anatomy and size of the lesion; Episealer toolkit; and Episealer Patellofemoral System, a system to treat osteoarthritis limited to the patellofemoral part of the knee joint.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis